Flavonoids’ Dual Benefits in Gastrointestinal Cancer and Diabetes: A Potential Treatment on the Horizon?
Open Access
Abstract
Diabetes and gastrointestinal cancers (GI) are global health conditions with a massive burden on patients’ lives worldwide. The development of both conditions is influenced by several factors, such as diet, genetics, environment, and infection, which shows a potential link between them. Flavonoids are naturally occurring phenolic compounds present in fruits and vegetables. Once ingested, unabsorbed flavonoids reaching the colon undergo enzymatic modification by the gut microbiome to facilitate absorption and produce ring fission products. The metabolized flavonoids exert antidiabetic and anti-GI cancer properties, targeting major impaired pathways such as apoptosis and cellular proliferation in both conditions, suggesting the potentially dual effects of flavonoids on diabetes and GI cancers. This review summarizes the current knowledge on the impact of flavonoids on diabetes and GI cancers in four significant pathways. It also addresses the synergistic effects of selected flavonoids on both conditions. While this is an intriguing approach, more studies are required to better understand the mechanism of how flavonoids can influence the same impaired pathways with different outcomes depending on the disease.Keywords
Funding Information
- Qatar National Research Fund (NPRP14S-0311-210033)
This publication has 130 references indexed in Scilit:
- Oxidative Stress in Diabetes: Implications for Vascular and Other ComplicationsInternational Journal of Molecular Sciences, 2013
- Flavonoid Bioavailability and Attempts for Bioavailability EnhancementNutrients, 2013
- Quercetin Protects against Diabetes-Induced Exaggerated Vasoconstriction in Rats: Effect on Low Grade InflammationPLOS ONE, 2013
- Molecular Basis of NF-κB SignalingAnnual Review of Biophysics, 2013
- Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part IEuropean Heart Journal, 2013
- Diabetes mellitus: An overview on its pharmacological aspects and reported medicinal plants having antidiabetic activityAsian Pacific Journal of Tropical Biomedicine, 2012
- AMP-activated protein kinase, stress responses and cardiovascular diseasesClinical Science, 2012
- Cellular Dysfunction in Diabetes as Maladaptive Response to Mitochondrial Oxidative StressExperimental Diabetes Research, 2012
- The AMPK signalling pathway coordinates cell growth, autophagy and metabolismNature Cell Biology, 2011
- Dietary Hesperidin Exerts Hypoglycemic and Hypolipidemic Effects in Streptozotocin-Induced Marginal Type 1 Diabetic RatsJournal of Clinical Biochemistry and Nutrition, 2009